MMW - Fortschritte der Medizin

, Volume 160, Supplement 1, pp 48–56 | Cite as

Gefürchtet, aber beherrschbar

Die Lungenarterienembolie

FORTBILDUNG . ÜBERSICHT
  • 29 Downloads

Zusammenfassung

Die Lungenarterienembolie kann akut tödlich verlaufen, rezidivieren und zu chronischen Langzeitkomplikationen führen. Daher ist richtiges Handeln in der Akutsituation und in der Langzeitbetreuung erforderlich. Da die Erkrankung lebensbedrohlich sein kann, die Therapie aber auch mit Risiken verbunden ist, gilt es, rasch Klarheit über die Diagnose zu erlangen. Diagnostik und Therapie in der Akutsituation sind genau festgelegt. In der Langzeitbetreuung können Unsicherheiten bestehen, die überlegtes Handeln erfordern.

Pulmonary embolism

Keywords

Anticoagulation medical aftercare prognosis dyspnea 

Literatur

  1. 1.
    Konstantinides S, Torbicki A, Agnelli G et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–69CrossRefGoogle Scholar
  2. 2.
    Konstantinides S, Bauersachs J, Mayer E, Hambrecht R. Kommentar zur 2014-ESC-Leitlinie zum Management der akuten Lungenembolie. Der Kardiologe. 2015;9:289–94CrossRefGoogle Scholar
  3. 3.
    Stein PD, Fowler SE, Goodman LR et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006; 354:2317–27CrossRefGoogle Scholar
  4. 4.
    Van Belle A, Büller HR, Huisman MV et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006;295:172–9CrossRefGoogle Scholar
  5. 5.
    Pollack CV, Schreiber D, Goldhaber SZ et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011;57:700–6CrossRefGoogle Scholar
  6. 6.
    Moser K M, Fedullo P F, LitteJohn J K, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994;271:223–5CrossRefGoogle Scholar
  7. 7.
    Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: in- creasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83:416–20CrossRefGoogle Scholar
  8. 8.
    Gibson NS, Sohne M, Kruip MJ, Tick LW, Gerdes VE, Bossuyt PM, Wells PS, Büller HR. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost. 2008;99:229–34PubMedGoogle Scholar
  9. 9.
    Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144:165–71CrossRefGoogle Scholar
  10. 10.
    Klok FA, Mos IC, Nijkeuter M, Righini M, Perrier A, Le Gal G, Huisman MV. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med. 2008;168:2131–6CrossRefGoogle Scholar
  11. 11.
    Sanchez O, Planquette B, Meyer G. Update on acute pulmonary embolism. Eur Respir Rev. 2009;18:137–47CrossRefGoogle Scholar
  12. 12.
    Righini M, Van Es J, Den Exter PL et al. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE Study. JAMA 2014;311:1117–24CrossRefGoogle Scholar
  13. 13.
    Bruno RR, Donner-Banzhoff N, Söllner W et al. Interdisziplinäre Versorgung akuter Thoraxschmerzen. Dtsch Arztebl Int. 2015;112:768–80PubMedPubMedCentralGoogle Scholar
  14. 14.
    Brown AK, Newton P, Hamilton EA et al. Recurrent pulmonary thromboembolism presenting with cardiac arrhythmias. Thorax. 1979;34:380–3CrossRefGoogle Scholar
  15. 15.
    Stein PD, Fowler SE, Goodman LR et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317–27CrossRefGoogle Scholar
  16. 16.
    Alderson PO. (1987) Scintigraphic evaluation of pulmonary embolism. Eur J Nucl Med. 1987;13(Suppl):S6–10PubMedGoogle Scholar
  17. 17.
    Reid JH, Coche EE, Inoue T et al. Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. Eur J Nucl Med Mol Imaging. 2009;36:505–21CrossRefGoogle Scholar
  18. 18.
    Jimenez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383–9CrossRefGoogle Scholar
  19. 19.
    Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost. 2011;9:2115–7CrossRefGoogle Scholar
  20. 20.
    Yusuff HO, Zochios V, Vuylsteke A. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review Perfusion. 2015;30:611–6PubMedGoogle Scholar
  21. 21.
    Van der Hulle T, Kooiman J, den Exter P L, Dekkers O M, Klok F A, Huisman M V. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thrombosis Haemostasis. 2014;12:320–8CrossRefGoogle Scholar
  22. 22.
    Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92:199–205CrossRefGoogle Scholar
  23. 23.
    Couturaud F, Sanchez O, Pernod G et al. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial. JAMA. 2015;314:31–40CrossRefGoogle Scholar
  24. 24.
    Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI, for the AMPLIFY Investigators. Apixaban for extended treatment of venous thromboembolism N Engl J Med. 2013;368:799–808CrossRefGoogle Scholar
  25. 25.
    Weitz J I, Lensing A W A, Prins M H, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton T A, Cohen A T, Davidson B L, Decousus H, Freitas M C S, Holberg G, Kakkar A K, Haskell L, van Bellen B, Pap A F, Berkowitz S D, Verhamme P, Wells P S, Prandoni P, for the EINSTEIN CHOICE Investigators. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med. 2017;376:1211–22CrossRefGoogle Scholar
  26. 26.
    Trujillo-Santos J, Prandoni P, Rivron-Guillot K et al. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008;6:251–5CrossRefGoogle Scholar
  27. 27.
    Held M, Joa F, Holl R. Lungenembolie, Diagnostik, Therapie und Nachsorge. Der Pneumologe. 2017;14:209–18CrossRefGoogle Scholar
  28. 28.
    Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Zarychanski R, Solymoss S, Routhier N, Douketis J, Danovitch K, Lee AY, Le Gal G, Wells PS, Corsi DJ, Ramsay T, Coyle D, Chagnon I, Kassam Z, Tao H, Rodger MA; SOME Investigators. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015;373:697–704CrossRefGoogle Scholar
  29. 29.
    Homewood R, Medford AR. Utility and prevalence of imaging for underlying cancer in unprovoked pulmonary embolism. J R Coll Physicians Edinb. 2015;45:206–8CrossRefGoogle Scholar
  30. 30.
    Pengo V, Lensing A W, Prins M H, Marchiori A, Davidson B L, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P for the Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257–64CrossRefGoogle Scholar
  31. 31.
    Riedel M, Stanek V, Widimsky J et al. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151–8CrossRefGoogle Scholar
  32. 32.
    Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, Ilkjaer L B, Klepetko W, Delcroix M, Lang I, Pepke-Zaba J, Simónneau G, Dartevelle P. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702–10CrossRefGoogle Scholar
  33. 33.
    Wilkens H, Konstantinides K, Lang I et al. Chronisch thromboembolische pulmonale Hypertonie (CTEPH); Dtsch Med Wochenschr. 2016;141:62–9CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • Matthias Held
    • 1
  • Franziska Joa
    • 2
  • Heinrike Wilkens
    • 3
  1. 1.Klinikum Würzburg Mitte, Standort Missioklinik, Innere Medizin, Pneumologie und Beatmungsmedizin, Onkologie und UmweltmedizinZentrum für pulmonale Hypertonie und LungengefäßkrankheitenWürzburgDeutschland
  2. 2.Zentrum für pulmonale Hypertonie und LungengefäßkrankheitenWürzburgDeutschland
  3. 3.Universitätsklinikum des SaarlandesHomburg/SaarDeutschland

Personalised recommendations